1. Home
  2. RPID vs MSD Comparison

RPID vs MSD Comparison

Compare RPID & MSD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RPID
  • MSD
  • Stock Information
  • Founded
  • RPID 2006
  • MSD 1993
  • Country
  • RPID United States
  • MSD United States
  • Employees
  • RPID N/A
  • MSD N/A
  • Industry
  • RPID Medical Specialities
  • MSD Trusts Except Educational Religious and Charitable
  • Sector
  • RPID Health Care
  • MSD Finance
  • Exchange
  • RPID Nasdaq
  • MSD Nasdaq
  • Market Cap
  • RPID 138.9M
  • MSD 159.3M
  • IPO Year
  • RPID 2021
  • MSD N/A
  • Fundamental
  • Price
  • RPID $3.47
  • MSD $7.68
  • Analyst Decision
  • RPID Buy
  • MSD
  • Analyst Count
  • RPID 1
  • MSD 0
  • Target Price
  • RPID $8.00
  • MSD N/A
  • AVG Volume (30 Days)
  • RPID 80.0K
  • MSD 70.2K
  • Earning Date
  • RPID 08-01-2025
  • MSD 01-01-0001
  • Dividend Yield
  • RPID N/A
  • MSD 11.26%
  • EPS Growth
  • RPID N/A
  • MSD N/A
  • EPS
  • RPID N/A
  • MSD N/A
  • Revenue
  • RPID $29,645,000.00
  • MSD N/A
  • Revenue This Year
  • RPID $18.54
  • MSD N/A
  • Revenue Next Year
  • RPID $20.55
  • MSD N/A
  • P/E Ratio
  • RPID N/A
  • MSD N/A
  • Revenue Growth
  • RPID 28.36
  • MSD N/A
  • 52 Week Low
  • RPID $0.61
  • MSD $6.11
  • 52 Week High
  • RPID $4.04
  • MSD $7.46
  • Technical
  • Relative Strength Index (RSI)
  • RPID 52.30
  • MSD 46.39
  • Support Level
  • RPID $3.45
  • MSD $7.60
  • Resistance Level
  • RPID $3.77
  • MSD $7.75
  • Average True Range (ATR)
  • RPID 0.23
  • MSD 0.08
  • MACD
  • RPID -0.02
  • MSD -0.03
  • Stochastic Oscillator
  • RPID 61.04
  • MSD 32.35

About RPID Rapid Micro Biosystems Inc.

Rapid Micro Biosystems Inc is an life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products such as biologics, vaccines, cell and gene therapies, and sterile injectables. The company's flagship Growth Direct platform automates and modernizes the antiquated, manual microbial quality control (MQC) testing workflows used in the pharmaceutical manufacturing operations across the globe. It derives revenue from development, manufacturing, marketing and selling Systems and related LIMS connection software, consumables and services.

About MSD Morgan Stanley Emerging Markets Debt Fund Inc.

Morgan Stanley Emerg Mkts Debt Fd Inc is a diversified, closed-end management investment company. The Fund's primary investment objective is to produce high current income and as a secondary objective to seek capital appreciation, through investments mainly in debt securities of government and government-related issuers located in emerging countries, of entities organized to restructure the outstanding debt of such issuers and debt securities of corporate issuers in or organized under the laws of emerging countries.

Share on Social Networks: